The clinicopathological characteristics of CCA patients, including age, sex, tumor staging, tumor size, tumor node metastasis (TMN), histological grading, and chemotherapy with respect to the level of LC3 and p62 expression in cancer cells and of IL-6 in CAFs are presented in Table 1. The gene discussed is MAP1LC3A; the disease is cholangiocarcinoma.